KennethRobertCookeMD
Pediatric Hematology & Oncology • Baltimore, MDProfessor of Oncology, Johns Hopkins University School of Medicine; Director, The Sidney Kimmel Comprehensive Cancer Center''s Division of Pediatic Oncology, Blood and Marrow Transplant Program
Dr. Cooke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans Street
Bloomberg 11N
Baltimore, MD 21287Phone+1 410-955-8751Fax+1 410-614-1802
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1993 - 1996
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1990 - 1993
Rutgers Robert Wood Johnson Medical SchoolClass of 1990
Certifications & Licensure
MD State Medical License 2013 - 2026
OH State Medical License 2008 - 2015
MI State Medical License 1999 - 2009
PA State Medical License 1992 - 1994
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 2008
Clinical Trials
- Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant Start of enrollment: 2006 Apr 01
- Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies Start of enrollment: 2015 Jan 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 766 citationsAn experimental model of idiopathic pneumonia syndrome after bone marrow transplantation : I. The roles of minor H antigens and endotoxinKenneth R. Cooke, Lester Kobzik, Thomas R. Martin, Joanne P. Brewer, John Delmonte
Blood. 1996-10-15 - 4 citationsHuman multipotent adult progenitor cells effectively reduce graft-vs-host disease while preserving graft-vs-leukemia activity.Leland Metheny, Saada Eid, Patiwet Wuttisarnwattana, Jeffery J. Auletta, Chen Liu
Stem Cells. 2021-11-01 - 225 citationsLPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.Kenneth R. Cooke, Armin Gerbitz, James M. Crawford, Takanori Teshima, Geoffrey R. Hill
The Journal of Clinical Investigation. 2001-06-15
Press Mentions
Johns Hopkins Brings Innovative Blood Stem Cell Transplant Treatments to PatientsJuly 31st, 2024
Fresh Strategies Aimed at Taming GVHDSeptember 20th, 2016- Multi-Institutional Prospective Research of Expanded Multi-Antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies (RESOLVE)July 30th, 2014
Grant Support
- Cytokine Modulation Strategies In Clinical Allogeneic BMTNational Cancer Institute2007–2008
- Mechanisms Of Leukocyte Recruitment During IPS After BMTNational Heart, Lung, And Blood Institute2007
- Cytokine Modulation Strategy In Clinical Allogeneic BMTNational Cancer Institute2004–2006
- Mechanisms Of Leukocyte Recruitment During IPS After BMTNational Heart, Lung, And Blood Institute2003–2006
- Pathophysiologic Mechanisms Of Lung Injury After BMTNational Heart, Lung, And Blood Institute1999–2000
- Pathophysiologic Mechanisms Of Lung Injury After BMTNational Heart, Lung, And Blood Institute1996–1998
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/kenneth-cooke
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
